Skip to main content
. 2023 Aug 29;106(4):369–376. doi: 10.1308/rcsann.2022.0140

Table 2 .

Univariate analysis of factors associated with positive peritoneal cytology for all oesophagogastric cancer patients

Negative cytology
(n=885)
Positive cytology
(n=81)
p-value
Age, median (IQR) 68 (59–74) 70 (61–77) 0.210
Male 487 (55) 47 (58) 0.312
Cancer site <0.001
 Oesophageal 283 (98) 8 (2)
 GOJ 368 (93) 29 (7)
 Gastric 234 (83) 59 (17)
OGD histology 0.041
 Adenocarcinoma 673 (93) 51 (7)
 Squamous cell carcinoma 59 (100) 2 (0)
 Other 64 (89) 8 (11)
EUS T stage 0.096
 T1–2 98 (99) 2 (1)
 T3 281 (99) 2 (1)
 T4 15 (94) 1 (6)
EUS N stage 0.963
 N0 163 (99) 2 (1)
 N1 197 (99) 2 (1)
 N2 18 (100) 0 (0)
 N3 4 (100) 0 (0)
CT T stage <0.001
 T1 60 (97) 2 (3)
 T2 147 (99) 1 (1)
 T3 581 (92) 54 (9)
 T4 47 (77) 14 (23)
CT N stage <0.001
 N0 407 (94) 25 (6)
 N1 327 (92) 28 (8)
 N2 89 (93) 7 (7)
 N3 11 (61) 7 (39)
PET 0.118
 M0 585 (97) 20 (3)
 M1 15 (88) 2 (12)

Values are given as n (%), unless noted otherwise.

CT = computed tomography; EUS = endoscopic ultrasound; GOJ = gastro-oesophageal junction; IQR = interquartile range; OGD = oesophagogastroduodenoscopy; PET = positron emission tomography